chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Acting really weird; Irritable; Wasn't thinking clearly; This spontaneous case was reported by a patient family member or friend (subsequently medically confirmed) and describes the occurrence of ABNORMAL BEHAVIOUR (Acting really weird), IRRITABILITY (Irritable) and THINKING ABNORMAL (Wasn't thinking clearly) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ABNORMAL BEHAVIOUR (Acting really weird) (seriousness criterion hospitalization), IRRITABILITY (Irritable) (seriousness criterion hospitalization) and THINKING ABNORMAL (Wasn't thinking clearly) (seriousness criterion hospitalization). At the time of the report, ABNORMAL BEHAVIOUR (Acting really weird), IRRITABILITY (Irritable) and THINKING ABNORMAL (Wasn't thinking clearly) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       On 25 Mar 2021, approximately 3 hours post vaccination, the reporter stated the patient lost his mind. The patient barrowed $6,000 for a motorcycle. Road the motorcycle into a snow storm. Went to jail for riding the motorcycle 130 miles per house. Has been scattered brain, incoherent. Tore up the vaccination card, threw hearing aids away, along with credit cards and cell phones. The reporter stated, the patient has been hospitalized in 3 psychiatric hospitals and at the time of this report, was hospitalized in one.   On 21 Apr 2021, the patient was normal for approximately 20 hours but resumed acting weird. The patient experiences brain fog in which he can't talk, had no refluxes, can't move but is able to hear.   Treatment information was not provided.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   This case was linked to (E2B Linked Report). Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Information has been received from a consumer concerning her 6 year old son, who on 13-AUG-2008 was vaccinated with VARIVAX (Merck), 0.5 mL, subcutaneously. Subsequently, on 23-AUG-2008, the child developed chicken pox. There was no concomitant medication. As of 28-AUG-2008, the date of this report, the child was recovering from chickenpox. The patient sought unspecified medical attention. No further information is available.
Narrative:  COVID infections following completion of COVID vaccine series 03/12/21 COVID vaccine dose #1 04/02/21 COVID vaccine dose #2 07/23/21 Pt reports cough, headache, runny nose, and close exposure to illness; tested and sent home; COVID POSITIVE 07/24/21 Pt reports diarrhea, fatigue, muscle pain, chills; rx given for acetaminophen, DM/guaifenesin, loperamide 07/25/21 Pt reports low grade fever temp 99.1 07/28/21 Pt reports dry cough increasing in frequency, continuous fatigue, constant headache, occasional nausea, and generalize muscle pain; remains stable 07/29/21 Pt reports shortness of breath 07/30/21 Pt reports occasional coughing, vomiting, but is stable 08/01/21 Pt reports pain when taking deep breath 08/03/21 Pt reports decreased coughing, easier breathing 08/04/21 Pt reports nausea 08/05/21 Pt reports fatigue but is improving; isolation end
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. Medical history and drug reactions or allergies were not specified. On 23-JUL-2014, the patient was vaccinated with a first dose of VAQTA strength reported as 25/0.5 (units not provided) (lot number not reported). The patient received the first dose of VAQTA subcutaneously rather than intramuscularly. No adverse symptoms were reported. Concomitant medications were not reported. Follow up information has been received from a pharmacist refers to the 69 years old female patient with no pre-existing allergies, birth defects or medical conditions. On 23-JUL-2014 PM, the patient was vaccinated with a first dose of VAQTA (subcutaneously, lot# reported as K006604). There was no illness at time of vaccination. Numerous checks had been done for the patient who demonstrated no adverse reactions except some soreness at injection site. Patient returned to record 1 m as appropriate. At the time of report, the status of patient was unknown. Additional information is not expected.
Fever mom didn't document night 13-14JUN but pt had t103 in office 14JUN; pt cried most of the night & much of next morning;
8 hours after receiving second shot, fever and child, body aches, head ache, nausea, digestive tract disturbances. Most effects went away within 48 hours. Since then, lower back has constant ache, also my body often feels cold.
She said last night her arm felt like it had fallen asleep. She said her arm had a tingling feeling in it, clarifying it was her arm that she received her COVID-19 Vaccine in on Saturday.; She also had a light bruise at the COVID-19 Vaccine injection site; This is a spontaneous report from a contactable consumer (reported for herself). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, Batch/Lot number and expiry date not reported), via an unspecified route of administration on 01May2021 as dose number unknown, single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On 01May2021, the patient felt her arm felt like it had fallen asleep, she said her arm had a tingling feeling in it, clarifying it was her arm that she received her vaccine. On an unspecified date in May2021 she also had a light, very faint bruise at the injection site. The outcome of the event tingling sensation was not recovered, and the outcome of the event bruising was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Swollen arm, muscle and joint aches, chills, elevated temp for 24-36 hours, temp between 100.6 and 101.8, diarrhea, exhaustion.. treated with Tylenol and water consumption
Serious fatigue, muscle ache, bone pain all over body. Random 'arthritis pain,' toes, fingers, arms, legs, everywhere. One area would hurt for a minute, then something else would hurt. No one place lasted more than a few seconds. But it just kept coming.    Over heated core temperature with cold hands and feet, woke me up from a deep sleep, but I was too weak and miserable to do anything about it, like peel the covers back to cool off. Miserable  Very similar reaction to each of the other vaccine doses in the series. But this was the worst.   Seems a very 'flu like,' response, only lasting about twelve hours. The worst of it was only three or four hours.   Once I was strong enough to get out of bed for more than a couple minutes, about six hours later, some Aleve really helped with the symptoms. Much better the evening following the injection. Still a little foggy and taking it slow, four days later.   Again, very similar reaction to the first three doses. I just did not report the symptoms then.
9/11: rash x 2 days, flu like symptoms x 1 week. 9/19: chest pain, palpitations. Improving. 9/22: headache, dysequilibrium. Persistent. No prior similar symptoms.
I got the shot in the afternoon of 2/24. I went home and had dinner and went directly to bed about 6. I didn't wake up until 3 am on 2/26.
Swollen lymph nodes in left armpit. I cannot put my arm completely down without hurting. My armpit is puffed out instead of curving inward. Also happened when I got my second dose 09/14/2021.
This spontaneous report as received from a medical assistant refers to a 14 year old patient of unknown gender. The patient's drug allergies and pertinent medical history was not reported. On 08-JUL-2014 the patient was vaccinated with first dose of GARDASIL (dose, frequency and route of administration were not reported) (lot # H020002, expiry date: 08-AUG-2015) which was stored improperly. No adverse effects were noted. No product quality complaint was reported for GARDASIL. This case is linked to 1407USA010956, 1407USA012902, 1407USA012903, 1407USA012904, 1407USA012906, 1407USA012907, 1407USA012908, 1407USA012909, 1407USA012910, 1407USA012911, 1407USA012912, 1407USA012913, 1407USA012914, 1407USA012915, 1407USA012916, 1407USA012917, 1407USA012918, 1407USA012919, 1407USA012920, 1407USA012921, 1407USA012922, 1407USA012923, 1407USA012924, 1407USA012925, 1407USA012926, 1407USA012927, 1407USA012928, 1407USA012929, 1407USA012930, 1407USA012931, 1407USA012932, 1407USA012933, 1407USA012934, 1407USA012935, 1407USA012937, 1407USA012938, 1407USA012939, 1407USA012940, 1407USA012941, 1407USA012942, 1407USA012943, 1407USA012944, 1407USA012945, 1407USA012946, 1407USA012947, 1407USA012948, 1407USA012949, 1407USA012950, 1407USA012951, 1407USA012952, 1407USA012953, 1407USA012954, 1407USA012955, 1407USA012956, 1407USA012957, 1407USA012958, 1407USA012959, 1407USA012960, 1407USA012961, 1407USA012962, 1407USA012963, 1407USA012964, 1407USA012965, 1407USA012966, 1407USA012967, 1407USA012968, 1407USA012969, 1407USA012970, 1407USA012971, 1407USA012972, 1407USA012973, 1407USA012974, 1407USA012975, 1407USA012976, 1407USA012977, 1407USA012978, 1407USA012979, 1407USA012980, 1407USA012981, 1407USA012982, 1407USA012983, 1407USA012984, 1407USA012985, 1407USA012986, 1407USA012987, 1407USA012988, 1407USA012989, 1407USA012990, 1407USA012991, 1407USA012992, 1407USA012993, 1407USA012994, 1407USA012995, 1407USA012996, 1407USA012997, 1407USA012998, 1407USA012999, 1407USA013000, 1407USA013013 and 1407USA013014 (same reporter link). Additional information has been requested.
15-20 seconds after vaccine administration pt. stated he wanted to sit for a few minutes. He then said he felt light headed, became pale and his head tipped back against the wall. Pt. loss consciousness,and exhibited seizure activity., 2 other RNs responded 911 initiated and pt. lowered to floor by 2 nurses. Pt. regained consciousness. pt. was diaphoretic and pale, BP was 122/72, and pulse was 56. Pt. transported via Search and Rescue to hospital ER which is in the same building as Public Health. Pt. did have emesis when on stretcher and declined Search and Rescue IV placement. Pt. gave permission for his Mother to be called which PH did.
My first symptoms started in the evening and I had a runny nose, scratchy throat, and cough.  the next morning and they did a COVID-19 test that came back positive. I contacted my doctor, and she prescribed Paxlovid. Within 12 hours of starting the medicine I was filling significantly better.  Most of my symptoms subsided except I still feel fatigued.
Immediate puffy swelling the size of a chickpea. The Pharmacist asked me before putting the bandaid on if I've ever had an allergic reaction before and I said no. As I looked at my arm and saw the swelling, I said "oh wow!" There was more blood than I've ever had with a shot before too. He advised me to go home and ice it and if I still had issues to take Benadryl. Once in the car I started feeling pain up into my neck and down into my fingertips. Once at home I iced my shoulder for quite some time and took benadryl. The arm pain was still present so I continued icing. The following day my arm was still swollen although instead of a chickpea lump at the immediate injection site, now the swelling was flatter and wider across my shoulder. Bruising was starting to form in the center. Pain is still in my neck, shoulder and down into my finger tips so I've been taking advil. Yesterday, 3 days after, there was still heat coming off the injection site. Today, 4 days after, it is bruised but not obviously swollen and there's less heat but the pain all up and down my arm persists.
Left side shoulder pain started the same day after flu shot on 10/14/2022  pain 8/10  Shoulder pain getting worse, hard to get dressed and it hurts to turn in bed  no noticed swelling or redness  thinks it is related to simvastatin , no treatment tried worried about nsaids side effects  feels the shoulder is tight  no new numbness or tingling  Rang of motion decreased  not associated with arm numbness / hand numbness or weakness . DM stable  HTN stable PT referral, orthopedic surgeon referral, shoulder X-ray, Sulindac 200 mg
Pt received with pneumonia vaccine in (L) deltoid and called back the next morning stating she had pain at the site. She was instructed to use TYLENOL and cool compress. Called her 9/18/08 at 8:30 an and pt reports much less pain. Denies erythema.
Sore arm to touch 5 days after vaccination, warm to touch, lump near injection site, headache
49yr patient with hx of Hashimoto who had received second dose at 10:58M, was observed to pass out while sitting on the observation area, as per paramedic patient (who was sitting right in front of him) pass out for 30 seconds while sitting on his chair. On my arrival patient awake, alert and oriented x3, seem a little pale, he was sitting up drinking water, he was taken to the examination room, laying flat on the stretcher, initial vital signs were BP 93/58 HR 48 RR 20, Sat 100% on room air, EKG long strip was done with showed sinus bradicardia, subsequent BP after 18 mins were 104/70 and then 114/69 HR 60. Patient denies shortness of breath, itchining or rash. fingerstick was 102mg/dL. (see below)
pink; itchy; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE ERYTHEMA (pink) and PRURITUS (itchy) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     Concomitant products included Blood thinner for an unknown indication.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced INJECTION SITE ERYTHEMA (pink) and PRURITUS (itchy). On 22-Jan-2021, PRURITUS (itchy) outcome was unknown. At the time of the report, INJECTION SITE ERYTHEMA (pink) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.        Treatment details included Ice   Reporter did not allow further contact
Information has been received from a medical assistant concerning a 25 year old female who on 23-JUN-2008 was vaccinated with a first dose of GARDASIL VACCINE 0.5 mL IM. The patient started getting a rash on her arms, but not around the injection site. On 25-JUN-2008, the patient called the office to report that the rash was all over her body and progressing. BENADRYL was recommended to the patient to treat the rash; however she reported that it did not seem to help. The patient was scheduled to be seen in the office on 26-JUN-2008 for an unrelated reason (sonogram). The patient's rash persisted. Additional information has been requested. This is in follow-up to report(s) previously submitted on 7/15/2008.  Information has been received from a medical assistant concerning a 25 year old female who at 1pm on 23-JUN-2008 was vaccinated with a first dose of GARDASIL 0.5 ml IM in her upper left arm (lot# 660553/0070X).  Thirty minutes after the injection, the patient started getting a rash on her arms and stomach but not around injection site and she felt light headed which lasted one hour.  One hour after the injection.  The patient experienced itching and a rash of small white bumps all over her body with no fever.  On 25-JUN-2008 the patient called the office to report that the rash was all over her body and progressing.  BENADRYL was recommended to the patient to treat the rash;  however she reported that it di not seem to help.  The patient was scheduled to be seen in the office on 26-JUN-2008 for an unrelated reason (sonogram and no result reported.  Subsequently, the patient recovered from the rash which lasted 7 days.  Additional information is not expected.
Pain from right breast bone - under arm to spine. Rash started after 2 days of just pain with spreading from breast bone on upper abdomen under arm to spine along the same plane.
This information has been received from a licensed practical nurse concerning a 2 year old patient of unspecified gender. On 19-SEP-2016, the patient was vaccinated with improperly stored (wistar ra 27-3) M-M-R II (lot # L036853, expiration date 24-SEP-2017) (dose#, dosage and route unspecified). The (wistar ra 27-3) M-M-R II  was exposed to temperature excursion potential of 72 F and 87.5 F on 17-JUN-216 and 22-JUL-2016 respectively. No adverse effects reported. No product quality complaint was involved. This is one of two reports from the same reporter. Additional information is not expected as no further information is available.
Big red welt at injection site; arm soreness; Hard (welt at injection site); red (welt at injection site); This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (Big red welt at injection site), PAIN IN EXTREMITY (arm soreness), VACCINATION SITE INDURATION (Hard (welt at injection site)) and VACCINATION SITE ERYTHEMA (red (welt at injection site)) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE MASS (Big red welt at injection site), PAIN IN EXTREMITY (arm soreness), VACCINATION SITE INDURATION (Hard (welt at injection site)) and VACCINATION SITE ERYTHEMA (red (welt at injection site)). At the time of the report, VACCINATION SITE MASS (Big red welt at injection site), PAIN IN EXTREMITY (arm soreness), VACCINATION SITE INDURATION (Hard (welt at injection site)) and VACCINATION SITE ERYTHEMA (red (welt at injection site)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.  Concomitant medication not provided. Treatment information not provided.
Cold sweats; low-grade fever; exhausted; lack of appetite; injection site pain; low-grade headache.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. No pertinent medical history or  drug reactions/allergies were provided. On an unspecified date in 2008, the patient was vaccinated with a dose of ZOSTAVAX (dose, route and lot number not provided), while in physician office. The pharmacist reported that on 23-JUN-2014, inadvertently, the patient received a second dose of ZOSTAVAX (dose, route and lot number not provided, location was unspecified). No adverse effects were reported. Additional information has been requested.
Severe coldness and violent tremors for about two hours, and 100 deg. fever all that night.
Fever, body aches, chills, headache, shortness of breath, nausea, exhaustion, right leg pain
Shingles manifesting as parathesia and blisters on the right torso (upper back, side of chest, below rib cage)
Patient said she was diagnosed with cellulitis on Friday. Called to report red at the injection site and she took BENADRYL. Also said she had SOB on Friday. Injection administered on Wednesday.
48 hours -- shaking chills without fever.    Drank extra water. Rested.  Could not be warm.  Dissipated after 48 hours.  Headache -- initially.   Tylenol.  Did not last more than an hour or two.
Swollen right deltoid, warm, no redness, chills, body aches, nausea, weakness.
drooping on one side of the face/ eye hurts to open and hurts to close it; Her eyes are droopy; "my eye is hurting so bad", it hurts to open and hurts to close it/pain in the eyes; Face is tender to the touch and hurts on that one side; Swelling of her left side of her face that hasn't gone down/swelling and drooping on one side of the face; This is a spontaneous report from a contactable nurse (patient). A 20-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number and expiry date were not provided), via an unspecified route of administration on 23Dec2020 at single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported.  Caller asking if pain in the eyes and swelling and drooping on one side of the face a side effect of the vaccine. Patient received the Covid vaccine on 23Dec2020 and noticed the next day (24Dec2020) swelling of her left side of her face that hasn't gone down. Her face is tender to the touch and hurts on that one side. Her eyes are droopy, "my eye is hurting so bad", it hurts to open and hurts to close it. The outcome of the events was unknown.   Information on the lot/batch number has been requested.; Sender's Comments: A possible causal association between administration of BNT162B2 and the onset eye hurts to open and hurts to close/ eyes droopy cannot be excluded, considering the plausible temporal relationship.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Initial information received on 01-Oct-2018 regarding an unsolicited valid non-serious case received from a consumer/non-hcp. This case involves a 46 years old male patient who experienced the next morning at around 5:30 am his heart rate was around 152, patient stated that by around 12:30am - 1am he was woken up due to shivering, he was diaphoretic and dizzy, he was diaphoretic and dizzy and said that his pulse was 106 at the doctors/ the lowest the heart rate would go to was 110, while he received vaccine DIPHTHERIA, TETANUS AND ACELLULAR PERTUSSIS VACCINE. The patients past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included INFLUENZA VACCINE for Immunisation. On 27-Sep-2018, the patient received a dose of suspect DIPHTHERIA, TETANUS AND ACELLULAR PERTUSSIS VACCINE produced by unknown manufacturer lot number not reported via intramuscular route. On 28-Sep-2018, the patient developed a non-serious the next morning at around 5:30 am his heart rate was around 152/ his pulse was 106 at the doctors/ the lowest the heart rate would go to was 110, non-serious patient stated that by around 12:30am -1am he was woken up due to shivering, he was diaphoretic and dizzy (hyperhidrosis) and diaphoretic and dizzy, (latency unknown) following the administration of DIPHTHERIA and TETANUS AND ACELLULAR PERTUSSIS VACCINE. (Other relevant tests included Patient did an EKG (Electrocardiogram) while he was at the office.) Final diagnosis was said that his pulse was 106 at the doctors/ the lowest the heart rate would go to was 110/ his pulse was 106 at the doctors/ the lowest the heart rate would go to was 110, he was diaphoretic and dizzy, he was diaphoretic and dizzy, patient stated that by around 12:30am- 1am he was woken up due to shivering and the next morning at around 5:30 am his heart rate was around 152. It was not reported if the patient received a corrective treatment. The patient outcome is reported as Unknown for the next morning at around 5:30 am his heart rate was around 152, as Unknown for patient stated that by around 12:30am- 1am he was woken up due to shivering, as Unknown for he was diaphoretic and dizzy, as Unknown for he was diaphoretic and dizzy and as Recovered / Resolved on an unknown date for said that his pulse was 106 at the doctors/ the lowest the heart rate would go to was 110.